Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
abandon, AccountingOfficer, ADAP, Addendum, airway, alfa, allograft, Ampac, ANDA, auxiliary, Bahama, Beecham, blocker, BNY, boosting, certiorari, cicletanine, citing, clarification, collaborationwithin, concentrated, concept, context, contingent, corroborated, coupon, Custodial, cycle, depleted, desire, diligent, dosage, double, downturn, embedded, escrow, essentially, EU, exempt, FAS, fifteenth, Fine, formal, genital, genotype, Grand, hierarchy, hydration, idiopathic, illiquidity, Imaging, inflammatory, inquiry, instance, IPF, Johnson, kidney, largest, leukemia, light, lymphocytic, lymphoma, MAA, macroeconomic, magnitude, manifestation, Master, mindful, mismatch, monotherapy, NBI, Neglected, nonalcoholic, ointment, organizational, papilloma, parasitic, passed, Patheon, perianal, permission, petition, PharmaChem, pharmacoenhancer, Port, preferential, presidential, proof, prudent, prudently, publish, reauthorized, reiterating, remanded, resource, restructuring, resubmit, revert, ribavirin, richard, robin, rollout, route, Ryan, salt, shortened, simultaneously, SmithKline, solution, sound, stand, standpoint, stavudine, stream, Supplementary, tempered, Teva, transplant, trend, Trustee, underinsured, unenforceable, uninsured, unobservable, upcoming, Velocity, whichever, White, whitley, wide, withdrawn, writ, Zerit
Removed:
Academy, accrual, ALT, amortizing, AST, Australian, bad, begun, Biochemistry, British, Cambridge, Center, chemistry, Chiron, clinic, closer, CMV, consent, credited, Czech, decided, depreciated, disputed, DNA, encountered, endothelial, expecting, Finally, flexibility, Fujisawa, greatest, half, histologically, installing, Institute, internet, involvement, Japanese, long, milligan, noncompetitive, Nonrefundable, obsolescence, occupy, Organic, paromomycin, percent, persistent, pertained, play, pound, proportional, proximity, purified, recruiting, rega, relocated, relocation, remained, render, repatriated, representative, Republic, restatement, reversal, serum, slower, Stichting, switch, traditionally, unbenefitted, underway, updating, upgrading, USA, vascular, VEGF, waive, weighted, wider
Filing tables
Filing exhibits
- 10-K Annual report
- 10.26 Gilead Sciences, Inc. 2005 Deferred Compensation Plan
- 10.27 Gilead Sciences, Inc. Severance Plan
- 10.53 Addendum to Tenofovir Disoproxil Fumarate Man. Supply Agreement
- 10.57 Purchase and Sale Agreement and Escrow Instructions
- 21.1 Subsidiaries of Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of CEO, As Required by Rule 13A-14(A) or Rule 15D-14(A)
- 31.2 Certification of CFO, As Required by Rule 13A-14(A) or Rule 15D-14(A)
- 32.1 Certifications of CEO and CFO, As Required by Rule 13A-14(B) or Rule 15D-14(B)
Related press release
GILD similar filings
Filing view
External links